Deals

Deal activity by volume related to ESG increased by 86% year-on-year in 2022 in the medical industry

Analysis of the key themes driving deal activity reveals that ESG accounted for 314 pharmaceutical deals between 2018 and 2022, worth a total value of $131,024m, according to GlobalData’s Deals database Analysis of the key themes driving deal activity reveals that ESG accounted for 126 medical deals between 2018 and 2022, worth a total value of $11,095m, according to GlobalData’s Deals database covering mergers and acquisitions, private equity, venture financing, equity offerings and partnerships. The $75m venture financing issue by RapidSOS was the largest disclosed deal in 2022, while the $15m venture financing issue by Hemanext was the largest disclosed deal in 2021. 

In volume terms, ESG-related deal activity increased by 86% year-on-year in 2022, whereas it decreased by 83% year-on-year in 2021. 

Deal activity related to ESG in the global medical industry in the last five years

Top deals related to ESG in the medical industry in the last five years

Deal volume by deal type for ESG related deals in the medical industry in the last five years 

Partnerships accounted for the highest number of deals in the last five years, with 41 deals, followed by venture financing (27 deals) and acquisitions (21 deals).

Top financial advisors for ESG related deals by value in the medical industry in the last five years 

The top financial advisors supporting deals related to ESG in the medical industry in the last five years in terms of value were Goldman Sachs International, Barclays Wealth Management, Deutsche Bank, J.P. Morgan Cazenove, and Rothschild.

Top legal advisors for ESG related deals by value in the medical industry in the last five years 

The top legal advisors supporting deals related to ESG in the medical industry in the last five years in terms of value were Allen & Overy, Arnold & Porter Kaye Scholer, Shearman & Sterling, Simpson Thacher & Bartlett, and Travers Smith.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s Deals database provides comprehensive coverage across industries tracking market activity of global mergers & acquisitions, including asset acquisitions/divestments; private equity deals (PE); venture finance deals (VC); equity offerings, including IPOs, follow-on offerings, and private placements; debt offerings, including private placements, ESG bonds and loans; partnerships; and licensing agreements. 

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumored deals. 

05/22/2024 23:11:23

Jobs

Hiring activity related to ESG increased by a CAGR of 51% in the medical industry since 2020

The global medical industry witnessed a 51% rise in compound annual growth rate (CAGR) in new job postings related to ESG since 2020, according to GlobalData's Job Analytics database. New job postings increased by 121% year-on-year in 2021, and by 4% year-on-year in 2022. 

Notably, management occupations jobs accounted for 22% share of the global medical industry’s ESG-related new job postings since 2020. 

Management occupations drive ESG-related hiring activity

Management occupations, with a share of 22%, emerged as the top ESG-related job roles within the medical industry since 2020, with new job postings rising by 116% year-on-year in 2021 and by 7% year-on-year in 2022. 

Architecture and engineering occupations came in second with a share of 12%, with new job postings rising by 88% year-on-year in 2021 and falling by 10% year-on-year in 2022. 

The other prominent ESG roles include computer and mathematical occupations with a 9% share, installation, maintenance, and repair occupations with a 9% share, and sales and related occupations with a 8% share. 

The top five companies in the medical industry accounted for 26% of hiring activity 

The top five companies, in terms of the number of new job postings tracked by GlobalData, since 2020 were Arjo, Danaher, Thermo Fisher Scientific, GE HealthCare Technologies, and Becton Dickinson. Together they accounted for a combined share of 26% of all ESG-related new jobs in the medical industry. 

Arjo posted 13,333 ESG-related jobs since 2020, followed by Danaher with 10,076 jobs, and Thermo Fisher Scientific with 9,583 jobs, according to GlobalData’s Job Analytics database. 

New job postings by Arjo increased by 759% year-on-year in 2021 and by 18% year-on-year in 2022, while those by Danaher increased by 71% in 2021 and decreased by 18% in 2022. 

Hiring activity was driven by the US with a 71% share of total new job postings since 2020 

The largest share of ESG-related new job postings in the medical industry since 2020 was in the US with 71%, followed by the UK (5%) and India (3%). The share represented by the US increased by five percentage points from 69% in 2021 to 74% in 2022.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s Job Analytics database uses machine learning to uncover key insights from tracking daily job postings for thousands of companies globally. Proprietary analysis is used to group jobs into key thematic areas and granular sectors across the world’s largest industries.

05/22/2024 23:11:23

Patents

Patent applications related to ESG increased by 3% per year on average in the medical industry since 2020

The global medical industry experienced a 3% increase in annual average growth rate (AAGR) in the number of ESG-related patent applications between 2020 and 2022. The total number of ESG-related grants increased by an AAGR of 8% during the same period, according to GlobalData's patent analytics database. 

Notably, the number of ESG-related patent applications in the medical industry was 15,265 since 2020, while 9,006 applications were granted.

The top five companies by filings accounted for 12% of patent applications

Analysis of patent applications by company shows that DexCom filed the most ESG patents within the medical industry since 2020. The company filed 247 ESG-related patents since 2020. 

It was followed by Johnson & Johnson (199 applications), Medtronic (127 applications), Japan Tobacco (117 applications) and ResMed (104 applications). 

The top five companies by grants accounted for 16% of successful patent grants

Analysis of patent grants by companies shows that DexCom was granted 198 patents related to ESG within the medical industry since 2020. It was followed by Johnson & Johnson (191 grants), Medtronic (115 grants), Japan Tobacco (75 grants) and DEKA Research and Development (49 grants).

Patent activity was driven by China with a 31% share of total patent publications

The largest share of ESG-related patent publications in the medical industry since 2020 was held by China with 31%, followed by the US (30%) and Japan (9%).

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s Patents Analytics tracks patent filings and grants from official patent offices around the world. Proprietary analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries

05/22/2024 23:11:23